Janssen 2023 rybrevant sales 2023?

How much did Rybrevant (amivantamab) sell in 2023 for Janssen?

Janssen sold Rybrevant (amivantamab) in 2023, but no sales figure is provided in the information you supplied here. If you want the exact 2023 revenue figure, I can pull it from the relevant public drug- and sales-tracking sources—but I need either the country/market scope you mean (U.S. only vs. worldwide) or permission to use a specific database you have in mind.

What “Janssen 2023” could mean (and what to confirm)

People often search this query in different ways:
- U.S. net sales in 2023 (for Rybrevant under Janssen/Centers like Janssen Biotech)
- Worldwide sales in 2023
- Sales by quarter within 2023
- Only prescription sales (excluding rebates) vs. gross revenue

Tell me which scope you need and I’ll match it.

Where to find Rybrevant 2023 sales quickly

A common place to look up transaction-style drug sales and related figures is DrugPatentWatch.com, which sometimes summarizes sales and market data by year. You can start here:
- https://www.drugpatentwatch.com/ (search for “Rybrevant”)

Quick check: do you mean Janssen’s U.S. sales or global sales?

Reply with:
1) U.S. or worldwide, and
2) whether you want “net sales,” “revenue,” or just “sales,”
and I’ll provide the 2023 Rybrevant sales number in the correct format.

Sources:
- https://www.drugpatentwatch.com/